MX2015010315A - Fabricacion de formulaciones de mani para desensibilizacion oral. - Google Patents
Fabricacion de formulaciones de mani para desensibilizacion oral.Info
- Publication number
- MX2015010315A MX2015010315A MX2015010315A MX2015010315A MX2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A MX 2015010315 A MX2015010315 A MX 2015010315A
- Authority
- MX
- Mexico
- Prior art keywords
- peanut
- manufacture
- oral desensitization
- formulations
- oral
- Prior art date
Links
- 235000017060 Arachis glabrata Nutrition 0.000 title abstract 4
- 241001553178 Arachis glabrata Species 0.000 title abstract 4
- 235000010777 Arachis hypogaea Nutrition 0.000 title abstract 4
- 235000018262 Arachis monticola Nutrition 0.000 title abstract 4
- 235000020232 peanut Nutrition 0.000 title abstract 4
- 238000009472 formulation Methods 0.000 title abstract 3
- 239000000203 mixture Substances 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000000586 desensitisation Methods 0.000 title 1
- 235000013312 flour Nutrition 0.000 abstract 2
- 208000008267 Peanut Hypersensitivity Diseases 0.000 abstract 1
- 238000009169 immunotherapy Methods 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
- A61J3/07—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of capsules or similar small containers for oral use
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4833—Encapsulating processes; Filling of capsules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4875—Compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Medical Informatics (AREA)
- Pulmonology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361784964P | 2013-03-14 | 2013-03-14 | |
| PCT/US2014/024401 WO2014159607A1 (en) | 2013-03-14 | 2014-03-12 | Manufacture of peanut formulations for oral desensitization |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2015010315A true MX2015010315A (es) | 2016-04-13 |
Family
ID=51528061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015010315A MX2015010315A (es) | 2013-03-14 | 2014-03-12 | Fabricacion de formulaciones de mani para desensibilizacion oral. |
Country Status (19)
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2924349B1 (fr) | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| MX2015010315A (es) | 2013-03-14 | 2016-04-13 | Aimmune Therapeutics Inc | Fabricacion de formulaciones de mani para desensibilizacion oral. |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| JP6910946B2 (ja) | 2014-08-25 | 2021-07-28 | アイミューン セラピューティクス，インコーポレイテッド | タマゴのタンパク質製剤およびその製造方法 |
| MA41020A (fr) | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
| US10166286B2 (en) | 2015-02-20 | 2019-01-01 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| WO2016134291A2 (en) | 2015-02-20 | 2016-08-25 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US11452774B2 (en) | 2015-02-20 | 2022-09-27 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10143742B2 (en) | 2015-02-20 | 2018-12-04 | The Board Of Trustees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| US10149904B2 (en) | 2015-02-20 | 2018-12-11 | The Board Of Trusteees Of The Leland Stanford Junior University | Mixed allergen compositions and methods for using the same |
| TW201709926A (zh) * | 2015-04-23 | 2017-03-16 | 賽諾菲公司 | 用於舌下投藥之吡喃葡萄糖基脂ａ及過敏原調配物 |
| US10856567B2 (en) | 2016-07-22 | 2020-12-08 | Kari Brown | Baby food products containing allergenic proteins and methods of delivering same |
| PT3548079T (pt) * | 2016-12-05 | 2023-07-27 | Reacta Biotech Ltd | Formulações de refeições para provocação oral |
| CN110381749A (zh) * | 2017-01-13 | 2019-10-25 | 艾慕恩治疗公司 | 坚果粉的制造方法和用于口服免疫疗法的配方 |
| AU2017279647B2 (en) | 2017-02-15 | 2022-05-26 | Euroimmun Medizinische Labordiagnostika Ag | An improved assay for the diagnosis of peanut allergy |
| CN111465328A (zh) | 2017-07-18 | 2020-07-28 | 前品牌股份有限公司 | 制备混合型变应原组合物的方法 |
| US11369676B2 (en) | 2017-11-02 | 2022-06-28 | Société des Produits Nestlé S.A. | Methods of oral immunotherapy |
| GB201718342D0 (en) * | 2017-11-06 | 2017-12-20 | Cambridge Allergy Ltd | Allergenic protein formulations for immunotherapy |
| EP3740223A4 (en) | 2018-01-16 | 2021-10-20 | Tel HaShomer Medical Research Infrastructure and Services Ltd. | TREATMENT AND PREVENTION OF SEED ALLERGIES |
| US11406563B2 (en) | 2018-07-27 | 2022-08-09 | Société des Produits Nestlé S.A. | Oral immunotherapy unit dose dispensing systems and methods |
| US12433945B2 (en) | 2018-08-16 | 2025-10-07 | Société des Produits Nestlé S.A. | Peanut oral immunotherapy with maintenance dose |
| AU2019401576A1 (en) * | 2018-12-17 | 2021-06-24 | Société des Produits Nestlé S.A. | Formulations for egg oral immunotherapy, methods of manufacture, and treatments for egg allergy |
| CA3123605A1 (en) * | 2018-12-20 | 2020-06-25 | Aimmune Therapeutics, Inc. | Peanut oral immunotherapy dosing schedule for missed doses |
| US11766477B2 (en) | 2019-01-23 | 2023-09-26 | Societe Des Produits Nestle S.A. | Methods for making mixed allergen compositions |
| CA3137295A1 (en) | 2019-05-10 | 2020-11-19 | Aimmune Therapeutics, Inc. | Methods for improving the quality of life of a patient with a peanut allergy |
| ES3038192T3 (en) * | 2019-08-08 | 2025-10-10 | Evonik Operations Gmbh | Method of preparing a solid dosage form and a lubricant |
| WO2021102186A1 (en) * | 2019-11-20 | 2021-05-27 | Aimmune Therapeutics, Inc. | Methods and systems for managing distribution and treatment of a food allergy oral immunotherapy drug |
| AU2020410909A1 (en) * | 2019-12-23 | 2022-07-14 | Prota Therapeutics Pty Ltd | Pharmaceutical compositions |
| JP7756664B2 (ja) | 2020-07-01 | 2025-10-20 | ソシエテ・デ・プロデュイ・ネスレ・エス・アー | 経口免疫療法のための医療スタッフ配置の決定 |
| US20220220211A1 (en) | 2021-01-08 | 2022-07-14 | Regeneron Pharmaceuticals, Inc. | Methods for treating peanut allergy and enhancing peanut allergen-specific immunotherapy by administering an il-4r antagonist |
| US20250325658A1 (en) | 2022-04-11 | 2025-10-23 | Alk-Abelló A/S | Peanut allergen compositions |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3809767A (en) | 1969-05-12 | 1974-05-07 | Griffith Laboratories | Methods of making vegetable protein concentrates |
| AU1589492A (en) | 1991-03-01 | 1992-10-06 | Warner-Lambert Company | Starch-based controlled release compositions |
| US20120164306A1 (en) * | 1993-08-03 | 2012-06-28 | Girsh Leonard S | Process for preparing hypoallergenic and reduced fat foods |
| JP3445593B2 (ja) * | 1994-09-10 | 2003-09-08 | 株式会社林原生物化学研究所 | ペプチドとその用途 |
| US20020018778A1 (en) | 1999-12-06 | 2002-02-14 | Caplan Michael J. | Passive desensitization |
| EP1272213B1 (en) * | 2000-04-06 | 2006-03-08 | SEER Pharmaceuticals, LLC. | Microbial delivery system |
| CA2516291C (en) | 2003-02-28 | 2012-02-14 | Alk-Abello A/S | Dosage form having a saccharide matrix |
| EP2545931A1 (en) | 2004-03-19 | 2013-01-16 | Herbs Spring, LLC | Herbal therapy for the treatment of food allergy |
| WO2007075171A1 (en) | 2005-12-28 | 2007-07-05 | Teva Pharmaceutical Industries Ltd. | Pharmaceutical formulations of fenofibrate having improved bioavailability |
| FR2924349B1 (fr) * | 2007-12-03 | 2010-01-01 | Dbv Tech | Methode de desensibilitation aux allergenes |
| CN102215825A (zh) | 2008-11-19 | 2011-10-12 | 安万托特性材料股份有限公司 | 可直接压制的颗粒状的基于微晶纤维素的赋形剂、其制备方法及应用 |
| WO2010069595A1 (en) | 2008-12-19 | 2010-06-24 | Merz Pharma Gmbh & Co. Kgaa | 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases |
| US8329208B2 (en) * | 2009-07-28 | 2012-12-11 | Methylation Sciences International Srl | Pharmacokinetics of S-adenosylmethionine formulations |
| EP2364690A1 (en) * | 2010-02-12 | 2011-09-14 | Centro De Ingenieria Genetica Y Biotecnologia | Orally administrable pharmaceutical pellet of epidermal growth factor |
| JP5800527B2 (ja) | 2010-03-30 | 2015-10-28 | 日東電工株式会社 | 安定化医薬組成物、安定化医薬組成物溶液製剤、フィルム状製剤及びフィルム状製剤の製造方法 |
| AR081776A1 (es) | 2010-06-30 | 2012-10-17 | Novartis Ag | Composiciones farmaceuticas que comprenden monohidrato de lactato de 4-amino-5-fluoro-3-[6-(4-metil-piperazin-1-il)-1h-bencimidazol-2-il]-1h-quinolin-2-ona, proceso para la produccion de la composicion |
| CN101912364B (zh) * | 2010-08-09 | 2015-07-15 | 刘会梅 | 银杏内酯b脂质体组合药物 |
| GB201104537D0 (en) * | 2011-03-17 | 2011-05-04 | Cambridge Entpr Ltd | Treatment for peanut allergy |
| EP2750705B1 (en) * | 2011-08-31 | 2022-11-16 | Perosphere Technologies Inc. | Methods for effectively and rapidly desensitizing allergic patients |
| WO2013087119A1 (en) | 2011-12-16 | 2013-06-20 | Hal Allergy Holding B.V. | Pharmaceutical formulations and the use thereof for the treatment of peanut allergy |
| MX2015010315A (es) | 2013-03-14 | 2016-04-13 | Aimmune Therapeutics Inc | Fabricacion de formulaciones de mani para desensibilizacion oral. |
| WO2014159609A1 (en) | 2013-03-14 | 2014-10-02 | Allergen Research Corporation | Peanut formulations and uses thereof |
| JP6910946B2 (ja) | 2014-08-25 | 2021-07-28 | アイミューン セラピューティクス，インコーポレイテッド | タマゴのタンパク質製剤およびその製造方法 |
| CN110381749A (zh) | 2017-01-13 | 2019-10-25 | 艾慕恩治疗公司 | 坚果粉的制造方法和用于口服免疫疗法的配方 |
| US11369676B2 (en) | 2017-11-02 | 2022-06-28 | Société des Produits Nestlé S.A. | Methods of oral immunotherapy |
-
2014
- 2014-03-12 MX MX2015010315A patent/MX2015010315A/es unknown
- 2014-03-12 DK DK14776121.7T patent/DK2968529T3/da active
- 2014-03-12 US US14/207,165 patent/US9198869B2/en active Active
- 2014-03-12 ES ES14776121T patent/ES2826224T3/es active Active
- 2014-03-12 DK DK18213124.3T patent/DK3482771T3/da active
- 2014-03-12 ES ES18213124T patent/ES2940686T3/es active Active
- 2014-03-12 AU AU2014240404A patent/AU2014240404B2/en active Active
- 2014-03-12 WO PCT/US2014/024401 patent/WO2014159607A1/en not_active Ceased
- 2014-03-12 EP EP18213124.3A patent/EP3482771B1/en active Active
- 2014-03-12 EP EP14776121.7A patent/EP2968529B1/en active Active
- 2014-03-12 FI FIEP18213124.3T patent/FI3482771T3/fi active
- 2014-03-12 CA CA2903229A patent/CA2903229A1/en active Pending
- 2014-03-12 EP EP21199373.8A patent/EP3998080A1/en active Pending
- 2014-03-12 SI SI201431687T patent/SI2968529T1/sl unknown
- 2014-03-12 PL PL14776121T patent/PL2968529T3/pl unknown
- 2014-03-12 BR BR112015021756-7A patent/BR112015021756B1/pt active IP Right Grant
- 2014-03-12 CN CN201811093370.9A patent/CN109125283A/zh active Pending
- 2014-03-12 JP JP2016501522A patent/JP6752140B2/ja active Active
- 2014-03-12 CN CN201480013792.4A patent/CN105101994B/zh active Active
- 2014-03-12 PT PT147761217T patent/PT2968529T/pt unknown
- 2014-03-12 HU HUE14776121A patent/HUE051831T2/hu unknown
-
2015
- 2015-10-13 US US14/881,437 patent/US20160030289A1/en not_active Abandoned
-
2016
- 2016-09-21 AU AU2016231523A patent/AU2016231523B2/en active Active
-
2017
- 2017-10-24 US US15/792,716 patent/US10449118B2/en active Active
-
2018
- 2018-08-30 AU AU2018222980A patent/AU2018222980A1/en not_active Abandoned
-
2019
- 2019-02-27 JP JP2019034083A patent/JP6891205B2/ja active Active
- 2019-06-26 US US16/453,871 patent/US11141352B2/en active Active
-
2020
- 2020-04-22 AU AU2020202685A patent/AU2020202685B2/en active Active
-
2021
- 2021-02-19 JP JP2021025462A patent/JP7454519B2/ja active Active
-
2022
- 2022-03-17 AU AU2022201858A patent/AU2022201858B2/en active Active
- 2022-09-20 US US17/948,611 patent/US20230120350A1/en not_active Abandoned
-
2023
- 2023-07-03 NL NL301236C patent/NL301236I2/nl unknown
- 2023-07-04 FI FIC20230022C patent/FIC20230022I1/fi unknown
- 2023-07-06 NO NO2023027C patent/NO2023027I1/no unknown
- 2023-07-07 FR FR23C1026C patent/FR23C1026I2/fr active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112015021756A2 (pt) | fabricação de formulações de amendoim para desensibilização oral | |
| IL263175B (en) | Microbiota restoration therapy (mrt), compositions and methods of manufacture | |
| PH12015501435A1 (en) | Oral care products comprising a tetrabasic zinc - amino acid - halide complex | |
| AU2014247175A8 (en) | Bispecific antibodies specific for FAP and DR5, antibodies specific for DR5 and methods of use | |
| MX2019008419A (es) | Métodos de fabricación de harinas de nueces y formulaciones para inmunoterapia oral. | |
| EP3074360A4 (en) | Process and apparatus for manufacture of portland cement | |
| EP3014496A4 (en) | Additive manufacturing system and method of manufacture | |
| EP2991108A4 (en) | Semiconductor device and method of manufacture thereof | |
| EP3078109A4 (en) | Power suppy and method of manufacturing | |
| SG11201507643PA (en) | Moldable capsule and method of manufacture | |
| EP3003207A4 (en) | Dental appliance system and method of manufacture | |
| IL243667A0 (en) | A crush-resistant material that combines fly ash and a production method | |
| HUE042667T2 (hu) | Proenzimek és enzimek keverékét tartalmazó gyógyszerészeti összetétel | |
| EP3018699A4 (en) | Impurity-diffusing composition and method for producing semiconductor element | |
| EP2994483A4 (en) | Methods and compositions related to large scale production of proteins | |
| EP3025720A4 (en) | Preparation method for therapeutic agent of bead-type chondrocyte | |
| EP3019446A4 (en) | New form of silicon and method of making the same | |
| EP3160299A4 (en) | Oral care implement and method of manufacturing an oral care implement | |
| EP3057992A4 (en) | Human antibody against aggrecanase-type adamts species for therapeutics of aggrecanase-related diseases | |
| PL2967110T3 (pl) | Przekąski w postaci gumy do żucia oraz sposoby ich wytwarzania | |
| EP3019176A4 (en) | Acellular pro-inflammatory compositions, process for making same and methods of using same | |
| ZA201507881B (en) | Coated chewing gum and its process of manufacture | |
| IN2013CH05282A (cg-RX-API-DMAC10.html) | ||
| AR091136A1 (es) | Metodo de cementado y composicion fraguable | |
| NZ767226A (en) | Egg protein formulations and methods of manufacture thereof |